Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Clinical Lymphoma, Myeloma & Leukemia|August 31, 2021
Late Responses in Patients With Chronic Myeloid Leukemia Initially Refractory to Tyrosine Kinase InhibitorsJustin Shaya, Kristen Pettit, Malathi Kandarpa, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 2, 2021
Real world use of FLT3 inhibitors for treatment of FLT3+ acute myeloid leukemia (AML): A single center, propensity-score matched, retrospective cohort studyBrian G Bazzell, Bernard L Marini, Lydia L Benitez, et al.
Leukemia & Lymphoma|November 20, 2019
Impact of prophylactic intrathecal chemotherapy on CNS relapse rates in AML patients presenting with hyperleukocytosisJustin H Reid, Anthony J Perissinotti, Lydia Benitez, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 22, 2021
Propensity-score Matched Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid LeukemiaJustin H Reid, Bernard L Marini, Lydia L Benitez, et al.
Frontiers in Oncology|June 9, 2025
A deep learning aided bone marrow segmentation of quantitative fat MRI for myelofibrosis patientsHumera Tariq, Lubomir Hadjiiski, Dariya Malyarenko, et al.
Magnetic Resonance in Medicine|January 24, 2024
Quantitative MRI reveals heterogeneous impacts of treatment on diseased bone marrow in a mouse model of myelofibrosisTanner H Robison, Winston Lee, Kathryn E Luker, et al.
Tomography (Ann Arbor, Mich.)|August 27, 2025
Fat Fraction MRI for Longitudinal Assessment of Bone Marrow Heterogeneity in a Mouse Model of MyelofibrosisLauren Brenner, Tanner H Robison, Timothy D Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 22, 2024
Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic AlterationsMalathi Kandarpa, Dan Robinson, Yi-Mi Wu, et al.
Leukemia & Lymphoma|November 7, 2023
Tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax and hypomethylating agents with or without dose ramp-upChristy J Khouderchah, Lydia L Benitez, Bernard L Marini, et al.
Pageof 4